2m 2m 2m 2m 2m 2m 2m
HUTCHMED Sp ADR (HCM)
NASDAQ
$10.14-$0.03 (-0.25%)
Price as of Jun 23, 2026 4:27 PM EDT- $1.7BMarket Cap
- -34.32%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
HUTCHMED Sp ADR (HCM)
$10.14-$0.03 (-0.25%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 393.5M -1.97% | 401.4M -52.10% | 838.0M +96.52% | 426.4M +19.73% | |
Cost of Revenue | 291.4M -1.21% | 294.9M -24.41% | 390.2M +45.21% | 268.7M +17.11% | |
Gross Profit | 310.3M +8.29% | 286.5M +0.76% | 284.4M +1.16% | 281.1M +10.20% | |
Sales and Marketing Expense | 36.3M -25.32% | 48.6M -8.94% | 53.4M +21.53% | 43.9M +16.14% | |
Research and Development Expense | -148.3M -30.09% | -212.1M -29.77% | -302.0M -178.06% | 386.9M +29.36% | |
Depreciation and Amortization Expense | 11.8M +4.26% | 11.3M +38.07% | 8.2M -5.27% | 8.7M +20.50% | |
Total Operating Expenses | 587.7M -12.80% | 673.9M -17.78% | 819.6M -1.74% | 834.1M +21.87% | |
Operating Profit | -39.2M -10.40% | -43.7M -337.85% | 18.4M +104.51% | -407.7M +24.18% | |
Interest Income | 49.9M +24.44% | 40.1M +10.89% | 36.1M +276.55% | 9.6M +362.38% | |
Interest Expense | N/A N/A | N/A N/A | -759,000 +16.41% | -652,000 +10.14% | |
Interest Income and Expense and Net | 49.9M +24.44% | 40.1M +13.27% | 35.4M +268.64% | 9.6M +362.38% | |
Total Nonoperating Income and Expense | 61.0M +43.09% | 42.6M +6.67% | 39.9M +1,563.28% | -2.7M -68.75% | |
Income before Taxes | 498.7M +45,148.87% | -1.1M -101.90% | 58.3M +114.21% | -410.4M +90.24% | |
Income Taxes | 63.6M +784.45% | 7.2M +59.50% | 4.5M +1,693.29% | -283,000 -102.37% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 456.9M +1,111.03% | 37.7M -62.56% | 100.8M +127.93% | -360.8M +85.38% | |
Net Income from Continuing Operations Applicable to Common | 456.9M +1,111.03% | 37.7M -62.56% | 100.8M +127.93% | -360.8M +85.38% | |
Basic EPS and Net Income | 0.53 +1,225.00% | 0.04 -66.67% | 0.12 +127.91% | -0.43 +72.00% | |
Diluted EPS and Net Income | 0.52 +1,200.00% | 0.04 -66.67% | 0.12 +127.91% | -0.43 +72.00% | |
Basic Weighted Average Shares | 858.3M +0.34% | 855.4M +0.67% | 849.7M +0.30% | 847.1M +6.87% | |
Diluted Weighted Average Shares | 872.9M +0.007% | 872.8M +0.42% | 869.2M +2.60% | 847.1M +6.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 71.3M -53.67% | 154.0M -45.71% | 283.6M -9.48% | 313.3M -17.02% | |
Short-Term Investments | 1.3B +89.98% | 682.2M +13.17% | 602.7M +89.71% | 317.7M -49.90% | |
Cash and Cash Equivalents and Short-Term Investments | 1.4B +63.53% | 836.1M -5.67% | 886.3M +40.47% | 631.0M -37.63% | |
Total Current Assets | 1.6B +46.95% | 1.1B -2.76% | 1.1B +30.59% | 839.9M -30.71% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | 36.9M +12.05% | |
Property and Plant and Equipment and Net | 94.6M +2.30% | 92.5M -7.25% | 99.7M +31.31% | 75.9M +84.00% | |
Total Long-Term Assets | 20.1M +30.19% | 15.4M +5.17% | 14.7M -6.80% | 15.7M -26.94% | |
Total Assets | 1.8B +37.58% | 1.3B -0.44% | 1.3B +24.32% | 1.0B -25.00% | |
Income Taxes Payable | 2.3M -48.49% | 4.5M +11.69% | 4.1M +6.33% | 3.8M -79.13% | |
Total Short-Term Debt | 25.0M +6.84% | 23.4M -24.98% | 31.2M +15.80% | 26.9M 0.00% | |
Total Current Liabilities | 315.8M -16.14% | 376.6M -6.57% | 403.0M +13.88% | 353.9M +13.55% | |
Total Long-Term Debt | 68.2M +14.73% | 59.4M +23.34% | 48.2M +166.18% | 18.1M -32.60% | |
Total Long-Term Liabilities | 6.3M -41.63% | 10.8M -4.49% | 11.3M -10.39% | 12.7M +9.50% | |
Total Liabilities | 501.8M -0.10% | 502.3M -6.35% | 536.4M +36.63% | 392.6M +17.84% | |
Retained Earnings | -378.6M -54.55% | -833.2M -4.33% | -870.9M -10.36% | -971.5M +59.17% | |
Total Stockholders Equity | 1.2B +62.90% | 759.9M +4.02% | 730.5M +19.69% | 610.4M -38.15% | |
Total Shares Outstanding | 872.3M +0.08% | 871.6M +0.04% | 871.3M +0.75% | 864.8M +0.03% | |
Cash Flow | |||||
Cash from Operating Activities | -64.7M -13,109.46% | 497,000 -99.77% | 219.3M +181.63% | -268.6M +31.52% | |
Capital Expenditures | 14.1M -21.11% | 17.9M -45.01% | 32.6M -11.05% | 36.7M +123.55% | |
Cash from Investing Activities | -29.4M -69.38% | -96.1M -67.01% | -291.1M -198.16% | 296.6M +196.82% | |
Dividends Paid | 1.0M 0.00% | 1.0M -88.97% | 9.1M -64.58% | 25.6M +158.74% | |
Cash from Financing Activities | 7.8M +125.55% | -30.7M -163.02% | 48.7M +158.79% | -82.8M -112.73% | |
Financials Ratio | |||||
Gross Margin | 25.95% -2.16% | 26.52% -50.37% | 53.44% +44.49% | 36.99% +3.98% | |
Operating Margin | -9.95% -8.60% | -10.89% -596.58% | 2.19% +102.29% | -95.61% +3.71% | |
Return on Assets | 30.19% +921.70% | 2.95% -66.15% | 8.73% +129.05% | -30.04% +61.81% | |
Return on Equity | 45.74% +803.47% | 5.06% -66.32% | 15.03% +133.27% | -45.18% +70.73% | |
Revenue Growth | -1.97% -96.22% | -52.10% -153.98% | 96.52% +389.11% | 19.73% -64.89% | |
Current Ratio | 4.96 +75.25% | 2.83 +4.07% | 2.72 +14.68% | 2.37 -38.98% | |
Cash Ratio | 0.23 -44.75% | 0.41 -41.88% | 0.70 -20.52% | 0.89 -26.93% | |
Debt-to-Equity Ratio | 0.08 -30.92% | 0.11 +0.37% | 0.11 +47.35% | 0.07 +35.23% | |
Debt-to-Assets Ratio | 0.05 -18.31% | 0.07 +4.84% | 0.06 +41.88% | 0.04 +11.48% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow